SectorBiological Technology
Established Date--
Listing Date28/04/2017
ExchangeNASDAQ Stock Exchange
Full-time Employees70
Fiscal Year Ends31/12
Security TypeCommon stock
Office address1717 Langhorne Newtown Road, Suite 300 Langhorne, Pennsylvania 19047
Business
IntroductionSavara Inc., was incorporated in Delaware in December 1995. The company is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Its only program, molgramostim inhalation solution (MOLBREEVI), is an investigational inhaled biologic that is in Phase 3 development for the treatment of autoimmune pulmonary alveolar proteinosis and has received Fast Track, Breakthrough Therapy and Orphan Drug designation.
